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Abstract Glial cell line-derived neurotrophic factor (GDNF)
has potentially great clinical importance in the treatment of
Parkinson’s disease and several other neurodegenerative dis-
eases, however its intracellular signaling mechanisms are poorly
understood. Here we show that upon GDNF binding glycosyl-
phosphatidylinositol (GPI)-linked GDNF receptor K1 (GFRK1)
activates cytoplasmic Src family tyrosine kinase(s) in Ret
tyrosine kinase-deficient cultured mouse dorsal root ganglion
neurons and in two Ret-negative cell lines. GFRK1-mediated Src-
type kinase activation subsequently triggers phosphorylation of
mitogen-activated protein kinase, cAMP response element
binding protein and phospholipase CQ. We therefore conclude
that GDNF can activate intracellular signaling pathways Ret-
independently via GPI-linked GFRK1.
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1. Introduction
Glial cell line-derived neurotrophic factor (GDNF) [1] is a
survival factor for embryonic midbrain dopaminergic neu-
rons, spinal motor neurons, locus coeruleus noradrenergic
neurons, and subpopulations of peripheral sensory, sympa-
thetic, and parasympathetic neurons. The pattern of neuro-
trophic activity of GDNF is therefore promising for its po-
tential use in the treatment of Parkinson’s disease, Alzheimer’s
disease, motoneuron diseases and several other neurodegener-
ative diseases [2,3]. The biological importance of GDNF is
illustrated by the phenotype of GDNF null mice which dis-
play de¢cits in primary sensory, sympathetic and motor neu-
rons, fail to develop kidneys and most of the enteric nervous
system, and die at birth [4^6]. Despite the potential clinical
importance of GDNF, the intracellular mechanism of
GDNF’s action is far from understood. GDNF has been
thought to act through a multicomponent receptor system
including a glycosyl-phosphatidylinositol (GPI)-linked
GDNF family receptor K1 (GFRK1) [7,8] and a transmem-
brane receptor tyrosine kinase, Ret [9,10]. GFRK1, lacking an
intracellular domain, was originally assessed as a binding site
for GDNF, serving only in the presentation of the GFRK1/
GDNF complex to Ret [7,8,11]. Recent data, however, sug-
gest that GFRK1 can evoke GDNF-induced intracellular sig-
naling in the absence of Ret [12]. Ret and GFRK1 expression
patterns, although similar, exhibit di¡erences in many tissues
[11,13,14], which may be a sign of the distinct signaling from
GRFK receptors alone or in conjunction with Ret tyrosine
kinase in trans [15]. We showed recently both in vitro and
in vivo [16] that GDNF promotes survival of postnatal coch-
lear sensory neurons expressing GFRK1 mRNA but lacking
Ret mRNA.
Here, we show that GDNF evokes Ret-independent signal-
ing via GFRK1. We found that GDNF-stimulated GFRK1
activates Src family tyrosine kinases. In the absence of Ret
GDNF-activated GFRK1/Src complex triggers phosphoryla-
tion of phospholipase CQ (PLCQ), ERK1/ERK2 kinases (mi-
togen-activated protein kinase, MAPK) and cAMP response
element binding protein (CREB) in Ret-de¢cient (Ret3=3)
dorsal root ganglion (DRG) neurons and in two Ret-negative
cell lines.
2. Materials and methods
2.1. Neuronal cultures
DRG from embryonic day 18 (E18) mice were treated with trypsin
(Worthington), non-neuronal cells removed by preplating, and about
95% pure neurons cultured on poly-ornithine-laminin-coated glass
coverslips in Ham’s F14 medium (Imperial Laboratories) with serum
substitute containing nerve frowth factor (NGF), brain-derived neuro-
trophic factor (BDNF) and NT-3 (all from PeproTech, 2 ng/ml each)
for at least 1 day before measurement. Neurotrophins were extensively
washed out before GDNF application. GDNF was from PeproTech
or donated by Cephalon, Inc. Ret3=3 mice [17] were identi¢ed from
heterozygote matings by the absence of kidneys and PCR-based geno-
typing.
2.2. RT-PCR analysis of GDNF receptors in the SHEP human
neuroblastoma cell line
In the RT-PCR analysis of SHEP cells we used the primers for
human GFRK1, GFRK2 and Ret. RT-PCR reaction was performed
using a Titan One Tube RT-PCR kit (Boehringer Mannheim) accord-
ing to the manufacturer’s instructions. The primer sequences and PCR
conditions were reported by Hishiki et al. [18].
2.3. Immunocomplex kinase assays and immunoblotting
DRG neurons (5U105), SHEP neuroblastoma cells (107) or
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NIH3T3 cells (NIH3T3/pBpGFRK1) stably transfected with GFRK1
(107) were incubated in serum-free culture medium without (control)
or with GDNF (GDNF-treated) for 0.5^15 min at 37‡C. The cells
were washed twice with cold phosphate bu¡ered saline (PBS) contain-
ing 1 mM vanadate and lysed in TX-100 lysis bu¡er (50 mM Tris^
HCl, pH 7.5, 150 mM NaCl, 5 mM EDTA, 1% Triton X-100, 1 mM
sodium orthovanadate, 1 mM phenylmethylsulfonyl £uoride and pro-
tease inhibitors (Boehringer)) on ice for 1 h. The postnuclear lysates
(supernatants obtained after centrifugation of the whole lysate at
2000 rpm) were precleared with 50% protein G-Sepharose (1 h at
+4‡C). The lysates were incubated with GFRK1 antibodies (Santa
Cruz Biotechnology) and immunocomplexes were collected with pro-
tein G-Sepharose. The immunocomplexes were washed twice with
TX-100 lysis bu¡er without EDTA and twice with kinase bu¡er
(25 mM HEPES, pH 7.4, 5 mM MgCl2, 5 mM MnCl2, 1 mM sodium
orthovanadate). The immunocomplexes were incubated in a kinase
bu¡er supplemented with 5 WCi of [Q-32P]ATP for 20 min at 37‡C.
The samples were subjected to 10% SDS-PAGE and Western blotting.
The radioactive signals were visualized with a Fuji Bioimage analyzer
BAS 2000. For immunoblotting the membranes were probed with Src-
2 antibodies (Santa Cruz Biotechnology) recognizing c-Src, Fyn and
Yes.
2.4. Immunoprecipitation and Western blotting of PLCQ
PLCQ was immunoprecipitated as described in [19] from the cell
lysate using anti-PLCQ antibodies (Upstate Biotechnology) and immu-
noblotted. The ¢lter was probed with anti-phosphotyrosine 4G-10
antibodies (Upstate Biotechnology). The membranes were stripped,
re-probed with anti-PLCQ antibodies and developed with ECL re-
agents.
2.5. MAPK and CREB phosphorylation assays
To assess GDNF-dependent MAPK and CREB phosphorylation in
SHEP cells and NIH3T3/pBpGFRK1 ¢broblasts, the cells were
starved overnight in medium containing 0.5% serum and for 3 h in
serum-free medium, and then GDNF was applied for the indicated
time. For the analysis of MAPK and CREB activation in Ret3=3
animals the DRG neurons were isolated from E18 mice and main-
tained in NGF-containing medium for 1 day. Then the neurons were
deprived of NGF by placing them in NGF-free medium in the pres-
ence of blocking anti-NGF antibodies (Boehringer). After 2 h without
NGF, the neurons were stimulated with GDNF. In the experiments
involving Src kinase inhibition, a Src family kinase inhibitor, PP2,
(Calbiochem) was added at the indicated concentrations to the cell
monolayers 10 min before GDNF application. The proteins from
whole cell lysates were resolved on SDS-PAGE and blotted. Western
blots were probed with polyclonal antibodies (pAbs) to the activated
forms of either MAPK (ERK1/2), JNK (Promega) or with an anti-
body that speci¢cally recognizes the Ser-133-phosphorylated form of
CREB (New England Biolabs). The blots were then reprobed with
GFRK1 monoclonal antibodies (mAbs) (Transduction Laboratories)
or CREB pAbs.
3. Results
3.1. GDNF stimulates GFRK1-coupled Src family kinases in
SHEP neuroblastoma cells
Human neuroblastoma SHEP cells lack Ret and GDNF
receptor K2 (GFRK2) mRNA but express GFRK1 mRNA
(Fig. 1A). The presence of GFRK1 protein and the absence
of Ret in these cells was further con¢rmed by Western blot-
ting (data not shown). GPI-linked proteins have been shown
to be localized to lipid rafts and directly associated with Src
family kinases [20]. In SHEP cells, GDNF (100 ng/ml) in-
creased the activity and protein amount of Src family kinases
(Fig. 1B) detected in co-immunoprecipitates with anti-GFRK1
antibodies from Triton X-100 postnuclear lysates (n = 5 inde-
pendent experiments). PLCQ has been shown to be a substrate
for Src family kinases [19]. In the whole cell lysates GDNF
rapidly activated PLCQ phosphorylation (Fig. 1C; n = 3 ex-
periments). It has been shown that activation of endogenous
Ret in PC12 cells as well as activation of transiently or stably
expressed Ret in COS-1 cells or NIH3T3 ¢broblasts leads to
the phosphorylation of c-Jun NH2-terminal protein kinase
(JNK) [20]. In our experiments GDNF (100 ng/ml) did not
evoke JNK activation in SHEP cells lacking Ret (n = 2 experi-
ments; data not shown).
3.2. GDNF activates ERK1/ERK2 and CREB
We further checked whether the activation of a GFRK1-
coupled kinase would lead to phosphorylation of the MAPKs
ERK1 and ERK2 in the absence of Ret, as Src kinases can
activate MAPK [21]. In SHEP cells application of GDNF
(100 ng/ml) evoked a rapid MAPK activation that lasted
less than 1 h (Fig. 2A, n = 4 experiments). This pattern of
MAPK activation was di¡erent from the elevation of
Fig. 1. GDNF activates Src family kinases associated with GFRK1
and induces PLCQ tyrosine phosphorylation in Ret-negative SHEP
cells. A: RT-PCR analysis shows that SHEP cells express only
GFRK1 (538 bp fragment), but not GFRK2 or Ret mRNA (ex-
pected fragments of 280 and 281 bp, respectively). H2O lane repre-
sent a negative control without added mRNA. B: Upper panel:
Triton X-100 postnuclear lysates of SHEP cells were immunopreci-
pitated (IP) with anti-GFRK1 antibodies and assayed for in vitro
kinase activity (n = 5 independent experiments). The cells were non-
treated (0 min) or treated with 100 ng/ml GDNF for the indicated
time. The optical density of the bands was determined using a phos-
phoimager and a TINA program and is presented as fold increase
relative to control (GDNF non-treated cells). Lower panel: After
the kinase assay the samples were analyzed by Western blotting
(WB) with Src-2 antibodies. C: Upper panel: SHEP cells were incu-
bated with indicated concentrations of GDNF for 1 or 5 min. PLCQ
proteins were immunoprecipitated from the lysates with anti-PLCQ
antibodies. The immunocomplexes were analyzed for tyrosine-phos-
phorylated proteins by WB using 4G-10 antibodies (K-PY). Lower
panel: The blot was re-probed with anti-PLCQ antibodies. In all
panels the numbers below lanes indicate fold induction of PLCQ
phosphorylation relative to control.
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MAPK phosphorylation observed in Ret/GFRK1-expressing
cells that lasted many hours [16] (Poteryaev, unpublished).
The GDNF-dependent phosphorylation of MAPK was
blocked by the Src-type kinase inhibitor PP2 already at a
low concentration (1 WM) (Fig. 2B, n = 2 separate experi-
ments). In another Ret-negative but GFRK1-expressing cell
line, 3T3NIH/pBpGFRK1 ¢broblasts, GDNF (100 ng/ml)
again increased phosphorylation of MAPK (n = 3 experi-
ments, data not shown), completely inhibitable by PP2. PP2
(0.1^10 WM) did not a¡ect NGF-dependent TrkA-mediated
activation of MAPK in PC12 (data not shown).
We further investigated whether GDNF a¡ects phospho-
rylation of CREB and we found that GDNF potently induced
phosphorylation of CREB at Ser-133 (Fig. 2C, n = 2 experi-
ments). Interestingly, GDNF also induced phosphorylation of
the CREB-related protein ATF-1 (Fig. 2C). The dynamics of
GDNF-induced Ret-independent CREB and ATF-1 phos-
phorylation was similar to that of GDNF-induced MAPK
phosphorylation.
3.3. GDNF activates a GFRK1-coupled kinase, MAPKs and
CREB in Ret3=3 DRG neurons
To study Ret-independent signaling via GFRK1 in primary
neurons, we used DRG neurons isolated from E18 Ret3=3
mice. In vitro kinase assay of immunoprecipitates with
GFRK1 antibodies from Triton X-100 postnuclear lysates of
GDNF-stimulated Ret3=3 DRG neurons revealed a major
phosphoprotein of approximately 60 kDa, which corresponds
to the Mr of several Src family tyrosine kinases (p59 Fyn,
pp60 Src and p62 Yes) (Fig. 3A).
In these neurons application of GDNF (100 ng/ml) evokes
a several-fold rapid activation of MAPK (n = 3 experiments,
Fig. 3B). BDNF has been shown to activate the Ras/ERK/
pp90 ribosomal S6 kinase pathway that culminates in CREB
phosphorylation [22]. We found that CREB phosphorylation
Fig. 2. GDNF evokes phosphorylation of MAPK, CREB and ATF-
1 in the Ret-negative SHEP neuroblastoma cell line. A: Upper pan-
el: Addition of GDNF evoked a transient and profound increase of
p42/p44 MAPK phosphorylation. The numbers below the lanes indi-
cate the fold induction of p42 phosphorylation relative to control.
Lower panel: Re-probing of the same ¢lter with anti-GFRK1 anti-
bodies. B: Upper panel: GDNF-induced phosphorylation of p42/
p44 MAPK was completely abolished by a 10-min pretreatment
with PP2. Lower panel: The blot was re-probed with the anti-
GFRK1 antibodies. C: Upper panel: GDNF treatment of SHEP
cells resulted in potent induction of CREB Ser-133 phosphorylation
as well as induced phosphorylation of the CREB-related protein
ATF-1. The numbers below the lanes indicate the fold induction of
CREB phosphorylation relative to control. Lower panel: Re-prob-
ing of the same ¢lter with anti-CREB antibodies.
Fig. 3. GDNF induces phosphorylation of MAPKs and CREB in
Ret3=3 DRG neurons. A: Panel 1: Triton X-100 postnuclear lysates
of GDNF (100 ng/ml, 5 min)-stimulated Ret3=3 mouse DRG neu-
rons were immunoprecipitated with GFRK1 antibodies, subjected to
an in vitro kinase assay and revealed a major phosphorylated V60
kDa band. Panel 2: This band was not seen in the control kinase
assay performed in Ret3=3 DRG neurons either with protein A-
Sepharose alone (a) or with bFGF antibodies instead of GFRK1
antibodies (b). B: Upper panel: GDNF induces phosphorylation of
p42 MAP kinases in Ret3=3 DRG neurons. The numbers below the
lanes indicate the fold induction of p42 band phosphorylation rela-
tive to control. Lower panel: Re-probing of the same ¢lter with
anti-GFRK1 mAb. C: Upper panel: GDNF induces an increase in
CREB Ser-133 phosphorylation. The numbers below the lanes indi-
cate the fold induction of CREB phosphorylation relative to con-
trol. Lower panel: Re-probing of the same ¢lter with anti-CREB
antibodies.
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at Ser-133 increased substantially already at 5 min after
GDNF treatment in Ret3=3 DRG neurons (Fig. 3C). We
did not observe GDNF-dependent phosphorylation of ATF-
1 found in SHEP cells (Fig. 2C).
4. Discussion
In this study we have shown using Ret3=3 DRG neurons
and two di¡erent Ret-negative cell lines that GDNF activates
Ret-independently Src family kinases and subsequently indu-
ces phosphorylation of ERK1/ERK2, CREB and ATF-1.
GDNF also evokes PLCQ phosphorylation in SHEP cells.
We therefore have demonstrated that GDNF can evoke
potent intracellular signaling not only via established the
GFRK1-Ret multicomponent receptor route [2,3,8^10], but
also through a Ret-independent GFRK1-mediated pathway.
According to current understanding [23] GPI-anchored pro-
teins, transmembrane tyrosine kinase proteins, G proteins and
acylated tyrosine kinases of the Src family can all associate
with so-called lipid rafts, a structure of sphingolipids and
cholesterol packed into moving platforms within the liquid
bilayer [23,24]. After Triton X-100 extraction, insoluble lipids
and proteins remain in the form of detergent-insoluble glyco-
lipid-enriched complexes or DIGs [23]. We found that Src
family kinases can be co-immunoprecipitated with GFRK1
antibodies from DIGs of Ret3=3 DRG neurons as well as
from two di¡erent Ret-negative but GFRK1-expressing cell
lines. In DIGs from SHEP neuroblastoma cells, GDNF
evoked a potent transient activation of Src family kinases.
These ¢ndings suggest that activation of Src family kinases
by GDNF in Ret-negative DRG neurons, neuroblastoma cells
and ¢broblasts might occur within the lipid rafts.
As in the wild type DRG neurons, GDNF evoked potent
activation of p42/p44 MAPK and CREB in the di¡erent Ret-
de¢cient cell lines. GDNF-evoked phosphorylation of MAPK
in SHEP cells was abolished with the selective Src kinase
inhibitor PP2. Thus GDNF-evoked Ret-independent phos-
phorylation of MAPK is completely dependent on the
GDNF-evoked activation of Src family kinases. Since the
studies on neuronal survival showed that MAPK e¡ectively
phosphorylates CREB, it was of great interest to reveal the
downstream targets of activated MAPK in Ret-negative neu-
rons and cell lines. Indeed, we detected signi¢cant GDNF-
dependent activation of CREB both in the Ret3=3 DRG neu-
rons and in the SHEP cells. Our results are therefore to some
extent contradictory to those of Trupp et al. [12] who found
that GDNF Ret-independently activates CREB phosphoryla-
tion but not the Ras/ERK pathway in the raphe nucleus-de-
rived RN33B cell line. Interestingly, we also observed a robust
GDNF-dependent activation of the CREB-related protein
ATF-1 in Ret-negative SHEP cells but not in the Ret3=3
DRG neurons. It is therefore possible that the discrepancies
between our results and those reported by Trupp et al. [12]
re£ect the di¡erences between the cells used. Ret-independent
GDNF-evoked activation of the transcription factors of the
CREB family can regulate gene expression. This can result in
profound changes in neuronal plasticity [22]. Unfortunately,
the study of the possible changes in neuronal plasticity in-
voked by GDNF in Ret3=3- or GFRK1-de¢cient neurons is
precluded by the early postnatal death of the knock-out ani-
mals. The morphological and biological consequences which
might be triggered by GDNF-evoked Ret-independent signal-
ing remain to be elucidated.
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